Bayer and Onyx Pharmaceuticals Announce FDA Priority Review Designation of Nexavar® (sorafenib) Supplemental New Drug…
Read More
Bayer and Onyx Pharmaceuticals Announce FDA Priority Review Designation of Nexavar® (sorafenib) Supplemental New Drug…
The ATA is pleased to confirm the launch of the ATA Corporate Information & Opportunities webpage which includes a link to the ATA corporate online news submission form.